Novozymes AS Profile

USD 0.000002  0.00%

Novozymes AS Summary

Novozymes AS (NVZMF) is traded on OTC Market in USA. It is located in Krogshoejvej 36 and employs 5,973 people. The company currently falls under 'Large-Cap' category with current market capitalization of 14.77 B. Novozymes AS has 293.5 M outstanding shares. NOVOZYMES A/S has accumulated about 104.21 M in cash with 669.95 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Check Novozymes AS Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 82.56%30 days 50.85  about 17.4%
Based on normal probability distribution, the odds of Novozymes AS to move above current price in 30 days from now is about 17.4% (This Novozymes AS probability density function shows the probability of Novozymes AS Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Everett Harris CoCommon Shares5.9 K310 K
Somerville Kurt FCommon Shares232 K13.2 M
View Novozymes AS Diagnostics

Novozymes AS Risk Profiles

Key Fundamentals

Novozymes AS Against Markets

Current Ratings

Novozymes AS 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for Novozymes AS are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novozymes AS produces and sells industrial enzymes and microorganisms worldwide. Novozymes AS was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes AS is traded on OTC Market in USA. more
NameNovozymes AS
CEO and PresPeder NielsenView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressKrogshoejvej 36
ExchangeOTC Market
Contact Number45 44 46 00 00
CurrencyUSD - US Dollar

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
View All  Next Launch Balance Of Power

Diversify with Novozymes AS

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Novozymes AS to your portfolio

Novozymes AS Dividends

Upcoming distributions to stockholders


Novozymes AS Corporate Directors
Kasim Kutay Director
Agnete RaaschouNielsen Director
Joergen Rasmussen Independent Director
Please see also Stocks Correlation. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.